BridgeBio Pharma Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | — | -5,752.0% | -6,127.9% |
| FY2021 | 95.5% | -827.1% | -841.2% |
| FY2022 | 95.6% | -659.6% | -624.2% |
| FY2023 | 73.7% | -6,528.8% | -7,021.9% |
| FY2024 | 98.3% | -267.2% | -244.9% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | — | -5,752.0% | -6,127.9% |
| FY2021 | 95.5% | -827.1% | -841.2% |
| FY2022 | 95.6% | -659.6% | -624.2% |
| FY2023 | 73.7% | -6,528.8% | -7,021.9% |
| FY2024 | 98.3% | -267.2% | -244.9% |